MELANIE VIRGILIO: Open Payments
NPI 1346707759 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$870 in 39 payments from 22 companies in 2025. Trend: 2023 $163 · 2024 $915 · 2025 $870
Food & beverage: $870
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $124 |
| Novartis Pharmaceuticals Corporation | 5 | $103 |
| Daiichi Sankyo Inc. | 4 | $85 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| ABBVIE INC. | 3 | $53 |
| Merck Sharp & Dohme LLC | 2 | $52 |
| PFIZER INC. | 2 | $40 |
| PharmaEssentia USA Corporation | 2 | $40 |
| Janssen Biotech, Inc. | 2 | $39 |
| EMD Serono, Inc. | 2 | $35 |
Products named: OJJAARA, KISQALI, LYNPARZA, Enhertu, Xtandi, BESREMI, RYBREVANT, VENCLEXTA.
Industry payments across PA — which companies pay providers there.
